Don’t miss our upcoming webinar with BioLife Solutions, ‘The importance of ice recrystallization for the cryopreservation of cell therapies.’
Register now >>> hubs.ly/Q04C2MhF0
Register now >>> hubs.ly/Q04C2MhF0
RegMedNet
Verified account This account is verified. Learn more@RegMedNet
Part of Taylor & Francis, features the latest news, opinions, insight and more on #regenerativemedicine, #cellandgenetherapy in partnership with @Regen_Med
1.3K Following 4.5K Followers 10K Posts
Latest posts 5
October's Industry updates from Dusko Ilic have landed! Get caught up on the latest developments, including:
💬Prime editing reaches the liver in Wilson disease
💬Two priority review vouchers worth US$413 million
💬All 28 patients in a pivotal β-thalassemia cohort stopped needing transfusions
hubs.ly/Q04DKKX20
💬Prime editing reaches the liver in Wilson disease
💬Two priority review vouchers worth US$413 million
💬All 28 patients in a pivotal β-thalassemia cohort stopped needing transfusions
hubs.ly/Q04DKKX20
www.regmednet.com Industry updates with Dusko Ilic: October 2026 Read highlights from Dusko Ilic’s industry news, including how sales of FDA priority review vouchers are funding programs without companies having to issue new shares. Catch up on this weeks cell and gene therapy news in just 5 minutes!
The FDA issued potency guidance for cell and gene therapy manufacturers and accepted uniQure’s BLA for its Huntington’s disease gene therapy for review. Plus, the MHRA approved an extension to the use of Casgevy for younger patients. Get the details in our weekly roundup >>> hubs.ly/Q04Dzf3y0
The FDA issued potency guidance for cell and gene therapy manufacturers and accepted uniQure’s BLA for its Huntington’s disease gene therapy for review. Plus, the MHRA approved an extension to the use of Casgevy for younger patients. Get the details in our weekly roundup >>> hubs.ly/Q04Dzf3y0
www.regmednet.com Cell therapy weekly: BLA for Huntington’s disease gene therapy accepted for review Catch up on top CGT news, including FDA's acceptance of uniQure's Biologics License Application (BLA) for its gene therapy for Huntington's disease for review. Discover how everyday handling and storage can trigger ice damage in cryopreserved cell therapies, and what you can do to protect them.
Register here >>> hubs.ly/Q04C2M050
Register here >>> hubs.ly/Q04C2M050
How do you overcome MSC variability to achieve reproducible, scalable results? Discover how a standardized UC-MSC source + defined expansion media can build a stronger foundation for MSC research.
Learn more >>> hubs.ly/Q04CQh590
Learn more >>> hubs.ly/Q04CQh590
